Real-world GLP-1 results fall short of clinical trials compared to surgery
NEWYou can now listen to Fox News articles!
Weight-loss surgery was shown to be five times more effective than weekly injections of popular GLP-1 receptor agonists, including semaglutide (such as Ozempic) and tirzepatide (such as Mounjaro).The finding comes from a recent study presented this week at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2025 Annual Scientific Meeting in Washington.Researchers looked at "real-world" electronic medical record data of 51,085 patients at NYU Langone Health and NYC Health + Hospitals.HAIRSTYLISTS AND MEDICAL EXPERT CONFIRM TEMPORARY HAIR LOSS AFFECTING OZEMPIC USERSAll patients had a body mass index (BMI) of at least 35. They had either undergone bariatric surgery (sleeve gastrectomy or Roux en-Y gastric bypass) or were prescrib...